Loading...
•
Mar 31
GE HealthCare Q1 2025 Earnings Report
GE HealthCare delivered solid revenue and profit growth in Q1 2025, supported by U.S. strength and increased orders.
Key Takeaways
GE HealthCare reported a strong start to 2025 with 4% organic revenue growth and notable profit expansion, supported by robust U.S. demand and operational execution.
Revenue reached $4.777 billion, growing 3% year-over-year (4% organic).
Net income rose to $564 million, a significant increase from $374 million last year.
Adjusted EPS improved to $1.01, supported by higher EBIT and lower taxes.
Board authorized a $1 billion share repurchase program.
GE HealthCare
GE HealthCare
GE HealthCare Revenue by Segment
GE HealthCare Revenue by Geographic Location
Revenue by Segment
Imaging Revenue
CapyFin.comAdvanced Visualization Revenue
CapyFin.comPatient Care Solutions Revenue
CapyFin.comPharmaceutical Diagnostics Revenue
CapyFin.comOther Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
GE HealthCare reaffirmed 2%-3% organic revenue growth but lowered EBIT and EPS guidance due to tariffs.
Positive Outlook
- Organic revenue growth guidance held steady at 2%–3%
- Adjusted EPS outlook of $3.90 to $4.10
- Adjusted ETR expected to improve to 21%-22%
- Free cash flow expected to be at least $1.2 billion
- Continued demand for imaging and diagnostics solutions
Challenges Ahead
- Adjusted EBIT margin guidance lowered to 14.2%-14.4%
- Full-year EPS forecast revised downward due to tariffs
- Tariff impact estimated at ~$0.85 in EPS
- Free cash flow guidance reduced from $1.75B to $1.2B
- Global trade environment remains a risk factor
Revenue & Expenses
Visualization of income flow from segment revenue to net income